Global Viral Vector and Vaccine Supply, Demand and Key Producers, 2023-2029
The global Viral Vector and Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Viral Vector and Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Viral Vector and Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Vector and Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Viral Vector and Vaccine total production and demand, 2018-2029, (K Units)
Global Viral Vector and Vaccine total production value, 2018-2029, (USD Million)
Global Viral Vector and Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Viral Vector and Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Viral Vector and Vaccine domestic production, consumption, key domestic manufacturers and share
Global Viral Vector and Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Viral Vector and Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Viral Vector and Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Viral Vector and Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ABL, Addgene, Aldevron, Boehringer Ingelheim International GmbH, Brammer Bio, Charles River Laboratories, Creative-Biogene, Fujifilm Corporation and General Electric, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Viral Vector and Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Viral Vector and Vaccine Market, By Region:
1. How big is the global Viral Vector and Vaccine market?
2. What is the demand of the global Viral Vector and Vaccine market?
3. What is the year over year growth of the global Viral Vector and Vaccine market?
4. What is the production and production value of the global Viral Vector and Vaccine market?
5. Who are the key producers in the global Viral Vector and Vaccine market?
6. What are the growth factors driving the market demand?
This report studies the global Viral Vector and Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Viral Vector and Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Vector and Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Viral Vector and Vaccine total production and demand, 2018-2029, (K Units)
Global Viral Vector and Vaccine total production value, 2018-2029, (USD Million)
Global Viral Vector and Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Viral Vector and Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Viral Vector and Vaccine domestic production, consumption, key domestic manufacturers and share
Global Viral Vector and Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Viral Vector and Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Viral Vector and Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Viral Vector and Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ABL, Addgene, Aldevron, Boehringer Ingelheim International GmbH, Brammer Bio, Charles River Laboratories, Creative-Biogene, Fujifilm Corporation and General Electric, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Viral Vector and Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Viral Vector and Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Adenovirus
- Fowlpox Virus
- Attenuated Yellow Fever
- Vaccinia Virus Vectors
- Research Institutes
- Biopharmaceutical Companies
- Others
- ABL
- Addgene
- Aldevron
- Boehringer Ingelheim International GmbH
- Brammer Bio
- Charles River Laboratories
- Creative-Biogene
- Fujifilm Corporation
- General Electric
- MerckKGaA
- Novasep
- Pfizer
- Spark Therapeutics
- Thermo Fisher Scientific
- Waisman Biomanufacturing
1. How big is the global Viral Vector and Vaccine market?
2. What is the demand of the global Viral Vector and Vaccine market?
3. What is the year over year growth of the global Viral Vector and Vaccine market?
4. What is the production and production value of the global Viral Vector and Vaccine market?
5. Who are the key producers in the global Viral Vector and Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Viral Vector and Vaccine Introduction
1.2 World Viral Vector and Vaccine Supply & Forecast
1.2.1 World Viral Vector and Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Viral Vector and Vaccine Production (2018-2029)
1.2.3 World Viral Vector and Vaccine Pricing Trends (2018-2029)
1.3 World Viral Vector and Vaccine Production by Region (Based on Production Site)
1.3.1 World Viral Vector and Vaccine Production Value by Region (2018-2029)
1.3.2 World Viral Vector and Vaccine Production by Region (2018-2029)
1.3.3 World Viral Vector and Vaccine Average Price by Region (2018-2029)
1.3.4 North America Viral Vector and Vaccine Production (2018-2029)
1.3.5 Europe Viral Vector and Vaccine Production (2018-2029)
1.3.6 China Viral Vector and Vaccine Production (2018-2029)
1.3.7 Japan Viral Vector and Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Viral Vector and Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Viral Vector and Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Viral Vector and Vaccine Demand (2018-2029)
2.2 World Viral Vector and Vaccine Consumption by Region
2.2.1 World Viral Vector and Vaccine Consumption by Region (2018-2023)
2.2.2 World Viral Vector and Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Viral Vector and Vaccine Consumption (2018-2029)
2.4 China Viral Vector and Vaccine Consumption (2018-2029)
2.5 Europe Viral Vector and Vaccine Consumption (2018-2029)
2.6 Japan Viral Vector and Vaccine Consumption (2018-2029)
2.7 South Korea Viral Vector and Vaccine Consumption (2018-2029)
2.8 ASEAN Viral Vector and Vaccine Consumption (2018-2029)
2.9 India Viral Vector and Vaccine Consumption (2018-2029)
3 WORLD VIRAL VECTOR AND VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Viral Vector and Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Viral Vector and Vaccine Production by Manufacturer (2018-2023)
3.3 World Viral Vector and Vaccine Average Price by Manufacturer (2018-2023)
3.4 Viral Vector and Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Viral Vector and Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Viral Vector and Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Viral Vector and Vaccine in 2022
3.6 Viral Vector and Vaccine Market: Overall Company Footprint Analysis
3.6.1 Viral Vector and Vaccine Market: Region Footprint
3.6.2 Viral Vector and Vaccine Market: Company Product Type Footprint
3.6.3 Viral Vector and Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Viral Vector and Vaccine Production Value Comparison
4.1.1 United States VS China: Viral Vector and Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Viral Vector and Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Viral Vector and Vaccine Production Comparison
4.2.1 United States VS China: Viral Vector and Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Viral Vector and Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Viral Vector and Vaccine Consumption Comparison
4.3.1 United States VS China: Viral Vector and Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Viral Vector and Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Viral Vector and Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Viral Vector and Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Viral Vector and Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Viral Vector and Vaccine Production (2018-2023)
4.5 China Based Viral Vector and Vaccine Manufacturers and Market Share
4.5.1 China Based Viral Vector and Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Viral Vector and Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Viral Vector and Vaccine Production (2018-2023)
4.6 Rest of World Based Viral Vector and Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Viral Vector and Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Viral Vector and Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Viral Vector and Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Viral Vector and Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Adenovirus
5.2.2 Fowlpox Virus
5.2.3 Attenuated Yellow Fever
5.2.4 Vaccinia Virus Vectors
5.3 Market Segment by Type
5.3.1 World Viral Vector and Vaccine Production by Type (2018-2029)
5.3.2 World Viral Vector and Vaccine Production Value by Type (2018-2029)
5.3.3 World Viral Vector and Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Viral Vector and Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Research Institutes
6.2.2 Biopharmaceutical Companies
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Viral Vector and Vaccine Production by Application (2018-2029)
6.3.2 World Viral Vector and Vaccine Production Value by Application (2018-2029)
6.3.3 World Viral Vector and Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 ABL
7.1.1 ABL Details
7.1.2 ABL Major Business
7.1.3 ABL Viral Vector and Vaccine Product and Services
7.1.4 ABL Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 ABL Recent Developments/Updates
7.1.6 ABL Competitive Strengths & Weaknesses
7.2 Addgene
7.2.1 Addgene Details
7.2.2 Addgene Major Business
7.2.3 Addgene Viral Vector and Vaccine Product and Services
7.2.4 Addgene Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Addgene Recent Developments/Updates
7.2.6 Addgene Competitive Strengths & Weaknesses
7.3 Aldevron
7.3.1 Aldevron Details
7.3.2 Aldevron Major Business
7.3.3 Aldevron Viral Vector and Vaccine Product and Services
7.3.4 Aldevron Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Aldevron Recent Developments/Updates
7.3.6 Aldevron Competitive Strengths & Weaknesses
7.4 Boehringer Ingelheim International GmbH
7.4.1 Boehringer Ingelheim International GmbH Details
7.4.2 Boehringer Ingelheim International GmbH Major Business
7.4.3 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Product and Services
7.4.4 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
7.4.6 Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
7.5 Brammer Bio
7.5.1 Brammer Bio Details
7.5.2 Brammer Bio Major Business
7.5.3 Brammer Bio Viral Vector and Vaccine Product and Services
7.5.4 Brammer Bio Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Brammer Bio Recent Developments/Updates
7.5.6 Brammer Bio Competitive Strengths & Weaknesses
7.6 Charles River Laboratories
7.6.1 Charles River Laboratories Details
7.6.2 Charles River Laboratories Major Business
7.6.3 Charles River Laboratories Viral Vector and Vaccine Product and Services
7.6.4 Charles River Laboratories Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Charles River Laboratories Recent Developments/Updates
7.6.6 Charles River Laboratories Competitive Strengths & Weaknesses
7.7 Creative-Biogene
7.7.1 Creative-Biogene Details
7.7.2 Creative-Biogene Major Business
7.7.3 Creative-Biogene Viral Vector and Vaccine Product and Services
7.7.4 Creative-Biogene Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Creative-Biogene Recent Developments/Updates
7.7.6 Creative-Biogene Competitive Strengths & Weaknesses
7.8 Fujifilm Corporation
7.8.1 Fujifilm Corporation Details
7.8.2 Fujifilm Corporation Major Business
7.8.3 Fujifilm Corporation Viral Vector and Vaccine Product and Services
7.8.4 Fujifilm Corporation Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Fujifilm Corporation Recent Developments/Updates
7.8.6 Fujifilm Corporation Competitive Strengths & Weaknesses
7.9 General Electric
7.9.1 General Electric Details
7.9.2 General Electric Major Business
7.9.3 General Electric Viral Vector and Vaccine Product and Services
7.9.4 General Electric Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 General Electric Recent Developments/Updates
7.9.6 General Electric Competitive Strengths & Weaknesses
7.10 MerckKGaA
7.10.1 MerckKGaA Details
7.10.2 MerckKGaA Major Business
7.10.3 MerckKGaA Viral Vector and Vaccine Product and Services
7.10.4 MerckKGaA Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 MerckKGaA Recent Developments/Updates
7.10.6 MerckKGaA Competitive Strengths & Weaknesses
7.11 Novasep
7.11.1 Novasep Details
7.11.2 Novasep Major Business
7.11.3 Novasep Viral Vector and Vaccine Product and Services
7.11.4 Novasep Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Novasep Recent Developments/Updates
7.11.6 Novasep Competitive Strengths & Weaknesses
7.12 Pfizer
7.12.1 Pfizer Details
7.12.2 Pfizer Major Business
7.12.3 Pfizer Viral Vector and Vaccine Product and Services
7.12.4 Pfizer Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Pfizer Recent Developments/Updates
7.12.6 Pfizer Competitive Strengths & Weaknesses
7.13 Spark Therapeutics
7.13.1 Spark Therapeutics Details
7.13.2 Spark Therapeutics Major Business
7.13.3 Spark Therapeutics Viral Vector and Vaccine Product and Services
7.13.4 Spark Therapeutics Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Spark Therapeutics Recent Developments/Updates
7.13.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.14 Thermo Fisher Scientific
7.14.1 Thermo Fisher Scientific Details
7.14.2 Thermo Fisher Scientific Major Business
7.14.3 Thermo Fisher Scientific Viral Vector and Vaccine Product and Services
7.14.4 Thermo Fisher Scientific Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Thermo Fisher Scientific Recent Developments/Updates
7.14.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.15 Waisman Biomanufacturing
7.15.1 Waisman Biomanufacturing Details
7.15.2 Waisman Biomanufacturing Major Business
7.15.3 Waisman Biomanufacturing Viral Vector and Vaccine Product and Services
7.15.4 Waisman Biomanufacturing Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Waisman Biomanufacturing Recent Developments/Updates
7.15.6 Waisman Biomanufacturing Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Viral Vector and Vaccine Industry Chain
8.2 Viral Vector and Vaccine Upstream Analysis
8.2.1 Viral Vector and Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Viral Vector and Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Viral Vector and Vaccine Production Mode
8.6 Viral Vector and Vaccine Procurement Model
8.7 Viral Vector and Vaccine Industry Sales Model and Sales Channels
8.7.1 Viral Vector and Vaccine Sales Model
8.7.2 Viral Vector and Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Viral Vector and Vaccine Introduction
1.2 World Viral Vector and Vaccine Supply & Forecast
1.2.1 World Viral Vector and Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Viral Vector and Vaccine Production (2018-2029)
1.2.3 World Viral Vector and Vaccine Pricing Trends (2018-2029)
1.3 World Viral Vector and Vaccine Production by Region (Based on Production Site)
1.3.1 World Viral Vector and Vaccine Production Value by Region (2018-2029)
1.3.2 World Viral Vector and Vaccine Production by Region (2018-2029)
1.3.3 World Viral Vector and Vaccine Average Price by Region (2018-2029)
1.3.4 North America Viral Vector and Vaccine Production (2018-2029)
1.3.5 Europe Viral Vector and Vaccine Production (2018-2029)
1.3.6 China Viral Vector and Vaccine Production (2018-2029)
1.3.7 Japan Viral Vector and Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Viral Vector and Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Viral Vector and Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Viral Vector and Vaccine Demand (2018-2029)
2.2 World Viral Vector and Vaccine Consumption by Region
2.2.1 World Viral Vector and Vaccine Consumption by Region (2018-2023)
2.2.2 World Viral Vector and Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Viral Vector and Vaccine Consumption (2018-2029)
2.4 China Viral Vector and Vaccine Consumption (2018-2029)
2.5 Europe Viral Vector and Vaccine Consumption (2018-2029)
2.6 Japan Viral Vector and Vaccine Consumption (2018-2029)
2.7 South Korea Viral Vector and Vaccine Consumption (2018-2029)
2.8 ASEAN Viral Vector and Vaccine Consumption (2018-2029)
2.9 India Viral Vector and Vaccine Consumption (2018-2029)
3 WORLD VIRAL VECTOR AND VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Viral Vector and Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Viral Vector and Vaccine Production by Manufacturer (2018-2023)
3.3 World Viral Vector and Vaccine Average Price by Manufacturer (2018-2023)
3.4 Viral Vector and Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Viral Vector and Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Viral Vector and Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Viral Vector and Vaccine in 2022
3.6 Viral Vector and Vaccine Market: Overall Company Footprint Analysis
3.6.1 Viral Vector and Vaccine Market: Region Footprint
3.6.2 Viral Vector and Vaccine Market: Company Product Type Footprint
3.6.3 Viral Vector and Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Viral Vector and Vaccine Production Value Comparison
4.1.1 United States VS China: Viral Vector and Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Viral Vector and Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Viral Vector and Vaccine Production Comparison
4.2.1 United States VS China: Viral Vector and Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Viral Vector and Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Viral Vector and Vaccine Consumption Comparison
4.3.1 United States VS China: Viral Vector and Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Viral Vector and Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Viral Vector and Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Viral Vector and Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Viral Vector and Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Viral Vector and Vaccine Production (2018-2023)
4.5 China Based Viral Vector and Vaccine Manufacturers and Market Share
4.5.1 China Based Viral Vector and Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Viral Vector and Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Viral Vector and Vaccine Production (2018-2023)
4.6 Rest of World Based Viral Vector and Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Viral Vector and Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Viral Vector and Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Viral Vector and Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Viral Vector and Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Adenovirus
5.2.2 Fowlpox Virus
5.2.3 Attenuated Yellow Fever
5.2.4 Vaccinia Virus Vectors
5.3 Market Segment by Type
5.3.1 World Viral Vector and Vaccine Production by Type (2018-2029)
5.3.2 World Viral Vector and Vaccine Production Value by Type (2018-2029)
5.3.3 World Viral Vector and Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Viral Vector and Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Research Institutes
6.2.2 Biopharmaceutical Companies
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Viral Vector and Vaccine Production by Application (2018-2029)
6.3.2 World Viral Vector and Vaccine Production Value by Application (2018-2029)
6.3.3 World Viral Vector and Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 ABL
7.1.1 ABL Details
7.1.2 ABL Major Business
7.1.3 ABL Viral Vector and Vaccine Product and Services
7.1.4 ABL Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 ABL Recent Developments/Updates
7.1.6 ABL Competitive Strengths & Weaknesses
7.2 Addgene
7.2.1 Addgene Details
7.2.2 Addgene Major Business
7.2.3 Addgene Viral Vector and Vaccine Product and Services
7.2.4 Addgene Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Addgene Recent Developments/Updates
7.2.6 Addgene Competitive Strengths & Weaknesses
7.3 Aldevron
7.3.1 Aldevron Details
7.3.2 Aldevron Major Business
7.3.3 Aldevron Viral Vector and Vaccine Product and Services
7.3.4 Aldevron Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Aldevron Recent Developments/Updates
7.3.6 Aldevron Competitive Strengths & Weaknesses
7.4 Boehringer Ingelheim International GmbH
7.4.1 Boehringer Ingelheim International GmbH Details
7.4.2 Boehringer Ingelheim International GmbH Major Business
7.4.3 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Product and Services
7.4.4 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
7.4.6 Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
7.5 Brammer Bio
7.5.1 Brammer Bio Details
7.5.2 Brammer Bio Major Business
7.5.3 Brammer Bio Viral Vector and Vaccine Product and Services
7.5.4 Brammer Bio Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Brammer Bio Recent Developments/Updates
7.5.6 Brammer Bio Competitive Strengths & Weaknesses
7.6 Charles River Laboratories
7.6.1 Charles River Laboratories Details
7.6.2 Charles River Laboratories Major Business
7.6.3 Charles River Laboratories Viral Vector and Vaccine Product and Services
7.6.4 Charles River Laboratories Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Charles River Laboratories Recent Developments/Updates
7.6.6 Charles River Laboratories Competitive Strengths & Weaknesses
7.7 Creative-Biogene
7.7.1 Creative-Biogene Details
7.7.2 Creative-Biogene Major Business
7.7.3 Creative-Biogene Viral Vector and Vaccine Product and Services
7.7.4 Creative-Biogene Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Creative-Biogene Recent Developments/Updates
7.7.6 Creative-Biogene Competitive Strengths & Weaknesses
7.8 Fujifilm Corporation
7.8.1 Fujifilm Corporation Details
7.8.2 Fujifilm Corporation Major Business
7.8.3 Fujifilm Corporation Viral Vector and Vaccine Product and Services
7.8.4 Fujifilm Corporation Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Fujifilm Corporation Recent Developments/Updates
7.8.6 Fujifilm Corporation Competitive Strengths & Weaknesses
7.9 General Electric
7.9.1 General Electric Details
7.9.2 General Electric Major Business
7.9.3 General Electric Viral Vector and Vaccine Product and Services
7.9.4 General Electric Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 General Electric Recent Developments/Updates
7.9.6 General Electric Competitive Strengths & Weaknesses
7.10 MerckKGaA
7.10.1 MerckKGaA Details
7.10.2 MerckKGaA Major Business
7.10.3 MerckKGaA Viral Vector and Vaccine Product and Services
7.10.4 MerckKGaA Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 MerckKGaA Recent Developments/Updates
7.10.6 MerckKGaA Competitive Strengths & Weaknesses
7.11 Novasep
7.11.1 Novasep Details
7.11.2 Novasep Major Business
7.11.3 Novasep Viral Vector and Vaccine Product and Services
7.11.4 Novasep Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Novasep Recent Developments/Updates
7.11.6 Novasep Competitive Strengths & Weaknesses
7.12 Pfizer
7.12.1 Pfizer Details
7.12.2 Pfizer Major Business
7.12.3 Pfizer Viral Vector and Vaccine Product and Services
7.12.4 Pfizer Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Pfizer Recent Developments/Updates
7.12.6 Pfizer Competitive Strengths & Weaknesses
7.13 Spark Therapeutics
7.13.1 Spark Therapeutics Details
7.13.2 Spark Therapeutics Major Business
7.13.3 Spark Therapeutics Viral Vector and Vaccine Product and Services
7.13.4 Spark Therapeutics Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Spark Therapeutics Recent Developments/Updates
7.13.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.14 Thermo Fisher Scientific
7.14.1 Thermo Fisher Scientific Details
7.14.2 Thermo Fisher Scientific Major Business
7.14.3 Thermo Fisher Scientific Viral Vector and Vaccine Product and Services
7.14.4 Thermo Fisher Scientific Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Thermo Fisher Scientific Recent Developments/Updates
7.14.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.15 Waisman Biomanufacturing
7.15.1 Waisman Biomanufacturing Details
7.15.2 Waisman Biomanufacturing Major Business
7.15.3 Waisman Biomanufacturing Viral Vector and Vaccine Product and Services
7.15.4 Waisman Biomanufacturing Viral Vector and Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Waisman Biomanufacturing Recent Developments/Updates
7.15.6 Waisman Biomanufacturing Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Viral Vector and Vaccine Industry Chain
8.2 Viral Vector and Vaccine Upstream Analysis
8.2.1 Viral Vector and Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Viral Vector and Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Viral Vector and Vaccine Production Mode
8.6 Viral Vector and Vaccine Procurement Model
8.7 Viral Vector and Vaccine Industry Sales Model and Sales Channels
8.7.1 Viral Vector and Vaccine Sales Model
8.7.2 Viral Vector and Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Viral Vector and Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Viral Vector and Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Viral Vector and Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Viral Vector and Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Viral Vector and Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Viral Vector and Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Viral Vector and Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Viral Vector and Vaccine Production Market Share by Region (2018-2023)
Table 9. World Viral Vector and Vaccine Production Market Share by Region (2024-2029)
Table 10. World Viral Vector and Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Viral Vector and Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Viral Vector and Vaccine Major Market Trends
Table 13. World Viral Vector and Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Viral Vector and Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Viral Vector and Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Viral Vector and Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Viral Vector and Vaccine Producers in 2022
Table 18. World Viral Vector and Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Viral Vector and Vaccine Producers in 2022
Table 20. World Viral Vector and Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Viral Vector and Vaccine Company Evaluation Quadrant
Table 22. World Viral Vector and Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Viral Vector and Vaccine Production Site of Key Manufacturer
Table 24. Viral Vector and Vaccine Market: Company Product Type Footprint
Table 25. Viral Vector and Vaccine Market: Company Product Application Footprint
Table 26. Viral Vector and Vaccine Competitive Factors
Table 27. Viral Vector and Vaccine New Entrant and Capacity Expansion Plans
Table 28. Viral Vector and Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Viral Vector and Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Viral Vector and Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Viral Vector and Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Viral Vector and Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Viral Vector and Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Viral Vector and Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Viral Vector and Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Viral Vector and Vaccine Production Market Share (2018-2023)
Table 37. China Based Viral Vector and Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Viral Vector and Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Viral Vector and Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Viral Vector and Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Viral Vector and Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Viral Vector and Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Viral Vector and Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Viral Vector and Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Viral Vector and Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Viral Vector and Vaccine Production Market Share (2018-2023)
Table 47. World Viral Vector and Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Viral Vector and Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Viral Vector and Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Viral Vector and Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Viral Vector and Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Viral Vector and Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Viral Vector and Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Viral Vector and Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Viral Vector and Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Viral Vector and Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Viral Vector and Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Viral Vector and Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Viral Vector and Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Viral Vector and Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. ABL Basic Information, Manufacturing Base and Competitors
Table 62. ABL Major Business
Table 63. ABL Viral Vector and Vaccine Product and Services
Table 64. ABL Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. ABL Recent Developments/Updates
Table 66. ABL Competitive Strengths & Weaknesses
Table 67. Addgene Basic Information, Manufacturing Base and Competitors
Table 68. Addgene Major Business
Table 69. Addgene Viral Vector and Vaccine Product and Services
Table 70. Addgene Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Addgene Recent Developments/Updates
Table 72. Addgene Competitive Strengths & Weaknesses
Table 73. Aldevron Basic Information, Manufacturing Base and Competitors
Table 74. Aldevron Major Business
Table 75. Aldevron Viral Vector and Vaccine Product and Services
Table 76. Aldevron Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Aldevron Recent Developments/Updates
Table 78. Aldevron Competitive Strengths & Weaknesses
Table 79. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 80. Boehringer Ingelheim International GmbH Major Business
Table 81. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Product and Services
Table 82. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 84. Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
Table 85. Brammer Bio Basic Information, Manufacturing Base and Competitors
Table 86. Brammer Bio Major Business
Table 87. Brammer Bio Viral Vector and Vaccine Product and Services
Table 88. Brammer Bio Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Brammer Bio Recent Developments/Updates
Table 90. Brammer Bio Competitive Strengths & Weaknesses
Table 91. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 92. Charles River Laboratories Major Business
Table 93. Charles River Laboratories Viral Vector and Vaccine Product and Services
Table 94. Charles River Laboratories Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Charles River Laboratories Recent Developments/Updates
Table 96. Charles River Laboratories Competitive Strengths & Weaknesses
Table 97. Creative-Biogene Basic Information, Manufacturing Base and Competitors
Table 98. Creative-Biogene Major Business
Table 99. Creative-Biogene Viral Vector and Vaccine Product and Services
Table 100. Creative-Biogene Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Creative-Biogene Recent Developments/Updates
Table 102. Creative-Biogene Competitive Strengths & Weaknesses
Table 103. Fujifilm Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Fujifilm Corporation Major Business
Table 105. Fujifilm Corporation Viral Vector and Vaccine Product and Services
Table 106. Fujifilm Corporation Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Fujifilm Corporation Recent Developments/Updates
Table 108. Fujifilm Corporation Competitive Strengths & Weaknesses
Table 109. General Electric Basic Information, Manufacturing Base and Competitors
Table 110. General Electric Major Business
Table 111. General Electric Viral Vector and Vaccine Product and Services
Table 112. General Electric Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. General Electric Recent Developments/Updates
Table 114. General Electric Competitive Strengths & Weaknesses
Table 115. MerckKGaA Basic Information, Manufacturing Base and Competitors
Table 116. MerckKGaA Major Business
Table 117. MerckKGaA Viral Vector and Vaccine Product and Services
Table 118. MerckKGaA Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. MerckKGaA Recent Developments/Updates
Table 120. MerckKGaA Competitive Strengths & Weaknesses
Table 121. Novasep Basic Information, Manufacturing Base and Competitors
Table 122. Novasep Major Business
Table 123. Novasep Viral Vector and Vaccine Product and Services
Table 124. Novasep Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Novasep Recent Developments/Updates
Table 126. Novasep Competitive Strengths & Weaknesses
Table 127. Pfizer Basic Information, Manufacturing Base and Competitors
Table 128. Pfizer Major Business
Table 129. Pfizer Viral Vector and Vaccine Product and Services
Table 130. Pfizer Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Pfizer Recent Developments/Updates
Table 132. Pfizer Competitive Strengths & Weaknesses
Table 133. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 134. Spark Therapeutics Major Business
Table 135. Spark Therapeutics Viral Vector and Vaccine Product and Services
Table 136. Spark Therapeutics Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Spark Therapeutics Recent Developments/Updates
Table 138. Spark Therapeutics Competitive Strengths & Weaknesses
Table 139. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 140. Thermo Fisher Scientific Major Business
Table 141. Thermo Fisher Scientific Viral Vector and Vaccine Product and Services
Table 142. Thermo Fisher Scientific Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Thermo Fisher Scientific Recent Developments/Updates
Table 144. Waisman Biomanufacturing Basic Information, Manufacturing Base and Competitors
Table 145. Waisman Biomanufacturing Major Business
Table 146. Waisman Biomanufacturing Viral Vector and Vaccine Product and Services
Table 147. Waisman Biomanufacturing Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Viral Vector and Vaccine Upstream (Raw Materials)
Table 149. Viral Vector and Vaccine Typical Customers
Table 150. Viral Vector and Vaccine Typical Distributors
Table 1. World Viral Vector and Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Viral Vector and Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Viral Vector and Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Viral Vector and Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Viral Vector and Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Viral Vector and Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Viral Vector and Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Viral Vector and Vaccine Production Market Share by Region (2018-2023)
Table 9. World Viral Vector and Vaccine Production Market Share by Region (2024-2029)
Table 10. World Viral Vector and Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Viral Vector and Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Viral Vector and Vaccine Major Market Trends
Table 13. World Viral Vector and Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Viral Vector and Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Viral Vector and Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Viral Vector and Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Viral Vector and Vaccine Producers in 2022
Table 18. World Viral Vector and Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Viral Vector and Vaccine Producers in 2022
Table 20. World Viral Vector and Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Viral Vector and Vaccine Company Evaluation Quadrant
Table 22. World Viral Vector and Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Viral Vector and Vaccine Production Site of Key Manufacturer
Table 24. Viral Vector and Vaccine Market: Company Product Type Footprint
Table 25. Viral Vector and Vaccine Market: Company Product Application Footprint
Table 26. Viral Vector and Vaccine Competitive Factors
Table 27. Viral Vector and Vaccine New Entrant and Capacity Expansion Plans
Table 28. Viral Vector and Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Viral Vector and Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Viral Vector and Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Viral Vector and Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Viral Vector and Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Viral Vector and Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Viral Vector and Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Viral Vector and Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Viral Vector and Vaccine Production Market Share (2018-2023)
Table 37. China Based Viral Vector and Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Viral Vector and Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Viral Vector and Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Viral Vector and Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Viral Vector and Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Viral Vector and Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Viral Vector and Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Viral Vector and Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Viral Vector and Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Viral Vector and Vaccine Production Market Share (2018-2023)
Table 47. World Viral Vector and Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Viral Vector and Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Viral Vector and Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Viral Vector and Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Viral Vector and Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Viral Vector and Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Viral Vector and Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Viral Vector and Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Viral Vector and Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Viral Vector and Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Viral Vector and Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Viral Vector and Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Viral Vector and Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Viral Vector and Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. ABL Basic Information, Manufacturing Base and Competitors
Table 62. ABL Major Business
Table 63. ABL Viral Vector and Vaccine Product and Services
Table 64. ABL Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. ABL Recent Developments/Updates
Table 66. ABL Competitive Strengths & Weaknesses
Table 67. Addgene Basic Information, Manufacturing Base and Competitors
Table 68. Addgene Major Business
Table 69. Addgene Viral Vector and Vaccine Product and Services
Table 70. Addgene Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Addgene Recent Developments/Updates
Table 72. Addgene Competitive Strengths & Weaknesses
Table 73. Aldevron Basic Information, Manufacturing Base and Competitors
Table 74. Aldevron Major Business
Table 75. Aldevron Viral Vector and Vaccine Product and Services
Table 76. Aldevron Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Aldevron Recent Developments/Updates
Table 78. Aldevron Competitive Strengths & Weaknesses
Table 79. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 80. Boehringer Ingelheim International GmbH Major Business
Table 81. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Product and Services
Table 82. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 84. Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
Table 85. Brammer Bio Basic Information, Manufacturing Base and Competitors
Table 86. Brammer Bio Major Business
Table 87. Brammer Bio Viral Vector and Vaccine Product and Services
Table 88. Brammer Bio Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Brammer Bio Recent Developments/Updates
Table 90. Brammer Bio Competitive Strengths & Weaknesses
Table 91. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 92. Charles River Laboratories Major Business
Table 93. Charles River Laboratories Viral Vector and Vaccine Product and Services
Table 94. Charles River Laboratories Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Charles River Laboratories Recent Developments/Updates
Table 96. Charles River Laboratories Competitive Strengths & Weaknesses
Table 97. Creative-Biogene Basic Information, Manufacturing Base and Competitors
Table 98. Creative-Biogene Major Business
Table 99. Creative-Biogene Viral Vector and Vaccine Product and Services
Table 100. Creative-Biogene Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Creative-Biogene Recent Developments/Updates
Table 102. Creative-Biogene Competitive Strengths & Weaknesses
Table 103. Fujifilm Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Fujifilm Corporation Major Business
Table 105. Fujifilm Corporation Viral Vector and Vaccine Product and Services
Table 106. Fujifilm Corporation Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Fujifilm Corporation Recent Developments/Updates
Table 108. Fujifilm Corporation Competitive Strengths & Weaknesses
Table 109. General Electric Basic Information, Manufacturing Base and Competitors
Table 110. General Electric Major Business
Table 111. General Electric Viral Vector and Vaccine Product and Services
Table 112. General Electric Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. General Electric Recent Developments/Updates
Table 114. General Electric Competitive Strengths & Weaknesses
Table 115. MerckKGaA Basic Information, Manufacturing Base and Competitors
Table 116. MerckKGaA Major Business
Table 117. MerckKGaA Viral Vector and Vaccine Product and Services
Table 118. MerckKGaA Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. MerckKGaA Recent Developments/Updates
Table 120. MerckKGaA Competitive Strengths & Weaknesses
Table 121. Novasep Basic Information, Manufacturing Base and Competitors
Table 122. Novasep Major Business
Table 123. Novasep Viral Vector and Vaccine Product and Services
Table 124. Novasep Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Novasep Recent Developments/Updates
Table 126. Novasep Competitive Strengths & Weaknesses
Table 127. Pfizer Basic Information, Manufacturing Base and Competitors
Table 128. Pfizer Major Business
Table 129. Pfizer Viral Vector and Vaccine Product and Services
Table 130. Pfizer Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Pfizer Recent Developments/Updates
Table 132. Pfizer Competitive Strengths & Weaknesses
Table 133. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 134. Spark Therapeutics Major Business
Table 135. Spark Therapeutics Viral Vector and Vaccine Product and Services
Table 136. Spark Therapeutics Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Spark Therapeutics Recent Developments/Updates
Table 138. Spark Therapeutics Competitive Strengths & Weaknesses
Table 139. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 140. Thermo Fisher Scientific Major Business
Table 141. Thermo Fisher Scientific Viral Vector and Vaccine Product and Services
Table 142. Thermo Fisher Scientific Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Thermo Fisher Scientific Recent Developments/Updates
Table 144. Waisman Biomanufacturing Basic Information, Manufacturing Base and Competitors
Table 145. Waisman Biomanufacturing Major Business
Table 146. Waisman Biomanufacturing Viral Vector and Vaccine Product and Services
Table 147. Waisman Biomanufacturing Viral Vector and Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Viral Vector and Vaccine Upstream (Raw Materials)
Table 149. Viral Vector and Vaccine Typical Customers
Table 150. Viral Vector and Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Viral Vector and Vaccine Picture
Figure 2. World Viral Vector and Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Viral Vector and Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Viral Vector and Vaccine Production (2018-2029) & (K Units)
Figure 5. World Viral Vector and Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Viral Vector and Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Viral Vector and Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Viral Vector and Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Viral Vector and Vaccine Production (2018-2029) & (K Units)
Figure 10. China Viral Vector and Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Viral Vector and Vaccine Production (2018-2029) & (K Units)
Figure 12. Viral Vector and Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Viral Vector and Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Viral Vector and Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Viral Vector and Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Viral Vector and Vaccine Markets in 2022
Figure 26. United States VS China: Viral Vector and Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Viral Vector and Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Viral Vector and Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Viral Vector and Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Viral Vector and Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Viral Vector and Vaccine Production Market Share 2022
Figure 32. World Viral Vector and Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Viral Vector and Vaccine Production Value Market Share by Type in 2022
Figure 34. Adenovirus
Figure 35. Fowlpox Virus
Figure 36. Attenuated Yellow Fever
Figure 37. Vaccinia Virus Vectors
Figure 38. World Viral Vector and Vaccine Production Market Share by Type (2018-2029)
Figure 39. World Viral Vector and Vaccine Production Value Market Share by Type (2018-2029)
Figure 40. World Viral Vector and Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Viral Vector and Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Viral Vector and Vaccine Production Value Market Share by Application in 2022
Figure 43. Research Institutes
Figure 44. Biopharmaceutical Companies
Figure 45. Others
Figure 46. World Viral Vector and Vaccine Production Market Share by Application (2018-2029)
Figure 47. World Viral Vector and Vaccine Production Value Market Share by Application (2018-2029)
Figure 48. World Viral Vector and Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Viral Vector and Vaccine Industry Chain
Figure 50. Viral Vector and Vaccine Procurement Model
Figure 51. Viral Vector and Vaccine Sales Model
Figure 52. Viral Vector and Vaccine Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Viral Vector and Vaccine Picture
Figure 2. World Viral Vector and Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Viral Vector and Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Viral Vector and Vaccine Production (2018-2029) & (K Units)
Figure 5. World Viral Vector and Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Viral Vector and Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Viral Vector and Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Viral Vector and Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Viral Vector and Vaccine Production (2018-2029) & (K Units)
Figure 10. China Viral Vector and Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Viral Vector and Vaccine Production (2018-2029) & (K Units)
Figure 12. Viral Vector and Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Viral Vector and Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Viral Vector and Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Viral Vector and Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Viral Vector and Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Viral Vector and Vaccine Markets in 2022
Figure 26. United States VS China: Viral Vector and Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Viral Vector and Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Viral Vector and Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Viral Vector and Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Viral Vector and Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Viral Vector and Vaccine Production Market Share 2022
Figure 32. World Viral Vector and Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Viral Vector and Vaccine Production Value Market Share by Type in 2022
Figure 34. Adenovirus
Figure 35. Fowlpox Virus
Figure 36. Attenuated Yellow Fever
Figure 37. Vaccinia Virus Vectors
Figure 38. World Viral Vector and Vaccine Production Market Share by Type (2018-2029)
Figure 39. World Viral Vector and Vaccine Production Value Market Share by Type (2018-2029)
Figure 40. World Viral Vector and Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Viral Vector and Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Viral Vector and Vaccine Production Value Market Share by Application in 2022
Figure 43. Research Institutes
Figure 44. Biopharmaceutical Companies
Figure 45. Others
Figure 46. World Viral Vector and Vaccine Production Market Share by Application (2018-2029)
Figure 47. World Viral Vector and Vaccine Production Value Market Share by Application (2018-2029)
Figure 48. World Viral Vector and Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Viral Vector and Vaccine Industry Chain
Figure 50. Viral Vector and Vaccine Procurement Model
Figure 51. Viral Vector and Vaccine Sales Model
Figure 52. Viral Vector and Vaccine Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
